Scientific publications

Aging Cell, 2025

Plasma Proteomic Signature as a Predictor of Age Advancement in People Living With HIV

Navas A., Matzaraki V., van Eekeren L. et al.

Journal of Bone and Mineral Research, 2025

Proteins and pathways involved in inflammation are longitudinally associated with total body bone mineral density among primarily hispanic overweight/obese adolescents and young adults

Beglarian E., Chen J., Li Z. et al.

Scientific Reports, 2025

Proteomic, metabolomic and lipidomic profiles in community acquired pneumonia for differentiating viral and bacterial infections

Rischke S., Gurke R., Zielbauer A. et al.

ESC Heart Failure, 2025

Pro‐adrenomedullin as an independent predictive biomarker for heart failure in atrial fibrillation and flutter

Hu G., Peng X., He L. et al.

Nature Communications, 2025

Proteomic signature of HIV-associated subclinical left atrial remodeling and incident heart failure

Peterson T., Hahn V., Moaddel R. et al.

Translational Psychiatry, 2025

Associations between biomarkers of inflammation and depressive symptoms—potential differences between diabetes types and symptom clusters of depression

Herder C., Zhu A., Schmitt A. et al.

Scientific Reports, 2025

Integrative bioinformatics approach identifies novel drug targets for hyperaldosteronism, with a focus on SHMT1 as a promising therapeutic candidate

Jia M., Lin L., Yu H. et al.

Nature Communications, 2025

Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients

Pickering H., Schaenman J., Phan H. et al.

Anesthesiology, 2025

Protein alterations in patients with delirium after cardiac surgery: An exploratory case-control sub-study of the VISION Cardiac Surgery Biobank

Spence J., Devereaux P., Bashir S. et al.

Journal of Hepatology, 2025

AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: two randomized phase I trials

Armisen J., Rauschecker M., Sarv J. et al.

Cell Reports Medicine, 2025

Phase 1/2 trial of brogidirsen: Dual-targeting antisense oligonucleotides for exon 44 skipping in Duchenne muscular dystrophy

Komaki H., Takeshita E., Kunitake K. et al.

Scientific Reports, 2025

The BAMBOO method for correcting batch effects in high throughput proximity extension assays for proteomic studies

Smits H., Delemarre E., Pandit A. et al.

Scientific Reports, 2025

Associations of serum and tissue TIMP1 with host response and survival in colorectal cancer

Kehusmaa A., Tuomisto A., Sirniö P. et al.

British Journal of Dermatology, 2025

High-throughput proteomics identifies inflammatory proteins associated with disease severity and genetic ancestry in patients with hidradenitis suppurativa

Dimitrion P., Krevh R., Veenstra J. et al.

Journal of Infection, 2025

MicroRNA biomarkers and host response pathways in severe pulmonary hemorrhagic syndrome due to leptospirosis: A multi-omics study

Tran P., Limothai U., Dinhuzen J. et al.

American Heart Journal, 2025

Elevated lipoprotein(a) levels are independently associated with the presence of significant coronary stenosis in de-novo patients with stable chest pain

Brix G., Rasmussen L., Rohde P. et al.

Molecular Medicine, 2025

Differential expression of plasma proteins and pathway enrichments in pediatric diabetic ketoacidosis

Spagnolo P., Cela E., Patel M. et al.

Cancer Medicine, 2025

Assessing the Causal Effect of Circulating Protein‐To‐Protein Ratio on the Risk of Morbidity of Hepatocellular Carcinoma

Yue Q., Li X., Wan X. et al.

Chinese Journal of Cancer Research, 2025

Efficacy, safety, and multi-omics analysis of pembrolizumab combined with nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: A single-arm phase 2 study

Gui L., Chen X., Zhang W. et al.

Frontiers in Oncology, 2025

Machine learning-based identification of proteomic markers in colorectal cancer using UK Biobank data

Radhakrishnan S., Nath D., Russ D. et al.